AbbVie
ABBV
ABBV
1,600 hedge funds and large institutions have $65.3B invested in AbbVie in 2015 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 684 increasing their positions, 578 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
0.53% less ownership
Funds ownership: 70.51% → 69.98% (-0.53%)
11% less capital invested
Capital invested by funds: $73.6B → $65.3B (-$8.29B)
14% less funds holding in top 10
Funds holding in top 10: 94 → 81 (-13)
Holders
1,600
Holding in Top 10
81
Calls
$1.09B
Puts
$815M
Top Buyers
| 1 | +$295M | |
| 2 | +$216M | |
| 3 | +$197M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$181M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$168M |
Top Sellers
| 1 | -$766M | |
| 2 | -$610M | |
| 3 | -$577M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$378M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$308M |